Civica Rx, the hospital-owned generic drug company, is collaborating with Vizient to help reduce drug shortages.

Pfizer plans to acquire Array BioPharma in a deal valued at $11.4 billion, the companies announced June 17.

Lupin Pharmaceuticals is recalling 18,408 bottles of an antibiotic from the U.S. market.

Three major U.S. drugmakers have sued HHS in an attempt to block a rule that would require them to disclose the list price of prescription drugs in their television advertisements, according to Bloomberg.

Bluebird Bio has priced Zynteglo, its gene therapy for a blood disorder, at $1.8 million, according to STAT news.

The owner of a pain clinic and pharmacy in Florida was sentenced to more than six years in prison and three years probation for his role in a $2.2 million insurance fraud scheme, according to the U.S. Justice Department.

Ten hospitals and health systems that posted job listings seeking pharmacy leaders in the last week:

A federal appeals court revived a class-action lawsuit alleging CVS Health overcharged millions of customers for generic drugs, according to the San Francisco Chronicle.

Four drugs or medical devices approved by the FDA since June 7:

Rita Shane, PharmD, FASHP, FCSHP,  first joined Los Angeles-based Cedars-Sinai Medical Center as an intern pharmacist, quickly rising through the ranks, serving as clinical coordinator and assistant director of pharmacy, prior to becoming director of pharmacy in 1988. In 2015,…